Literature DB >> 18439167

Lead-associated endocarditis: the important role of methicillin-resistant Staphylococcus aureus.

Arnold J Greenspon1, Eugene S Rhim, George Mark, Joseph Desimone, Reginald T Ho.   

Abstract

BACKGROUND: Infection is a potentially life-threatening complication of cardiac device implantation. Lead-associated endocarditis (LAE) may be the most serious complication since it is associated with a high mortality.
METHODS: The medical records of patients referred to our institution for the treatment of LAE between 1999 and 2007 were reviewed.
RESULTS: A total of 51 of 107 patients referred for device-related infections met the criteria for LAE. Of these, 19 occurred within 6 months of their most recent procedure (early), while the remaining 32 occurred more than 6 months later (mean = 31.9 months post procedure). Devices included pacemakers in 33 patients and ICDs in 18 patients. The most common organism responsible for infection was Staphylococcus aureus (S. aureus) followed by coagulase-negative staphylocci (22%) and streptococci (12%). Methicillin-resistant S. aureus (MRSA) accounted for 67% of the S. aureus infections. Coagulase-negative staphylococci were responsible for only 26% of early and 19% of late cases. A distant site of infection was common (26/51 = 51%), particularly in patients with MRSA LAE. The device and leads were removed percutaneously in all patients. Only one patient failed to respond to intravenous antibiotics.
CONCLUSIONS: Our data suggest that methicillin-resistant S. aureus is an important pathogen in LAE. Since many infections occur months after the last device procedure, hematogenous spread of organisms from a distant site may be an important contributing factor. These data suggest that strategies to prevent hematogenous infection, particularly with S. aureus, are critical in patients with implantable cardiac devices.

Entities:  

Mesh:

Year:  2008        PMID: 18439167     DOI: 10.1111/j.1540-8159.2008.01039.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  10 in total

1.  Cardiac implantable electronic devices in end-stage renal disease patients: preservation of central venous circulation.

Authors:  Gustavo Lopera; Gerald A Beathard; Jose Exaire; Roger Carrillo
Journal:  J Interv Card Electrophysiol       Date:  2012-06       Impact factor: 1.900

Review 2.  [What must intensive care physicians know about implantable cardioverter defibrillator?].

Authors:  E Gatterer
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-09-20       Impact factor: 0.840

3.  Cardiac Implantable Electronic Device Infection in Patients at Risk.

Authors:  Khaldoun G Tarakji; Christopher R Ellis; Pascal Defaye; Charles Kennergren
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-05

4.  Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB).

Authors:  M Rizwan Sohail; Bharath Raj Palraj; Sana Khalid; Daniel Z Uslan; Farah Al-Saffar; Paul A Friedman; David L Hayes; Christine M Lohse; Walter R Wilson; James M Steckelberg; Larry M Baddour
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-12-12

5.  Rate, Time Course, and Predictors of Implantable Cardioverter Defibrillator Infections: An Analysis From the SIMPLE Trial.

Authors:  François Philippon; Gilles E O'Hara; Jean Champagne; Stefan H Hohnloser; Michael Glikson; Jörg Neuzner; Philippe Mabo; Xavier Vinolas; Josef Kautzner; Fredrik Gadler; Noa Lashevsky; Stuart J Connolly; Yan Y Liu; Jeff S Healey
Journal:  CJC Open       Date:  2020-04-25

6.  Management of Cardiovascular Implantable Electronic Devices Infections in High-Risk Patients.

Authors:  Charles Kennergren
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-04-10

7.  Clinical manifestations of lead-dependent infective endocarditis: analysis of 414 cases.

Authors:  A Polewczyk; M Janion; R Podlaski; A Kutarski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-03       Impact factor: 3.267

8.  Clinical manifestations of device-related infective endocarditis in cardiac resynchronization therapy recipients.

Authors:  Ewa Jędrzejczyk-Patej; Michał Mazurek; Oskar Kowalski; Adam Sokal; Agnieszka Liberska; Mariola Szulik; Tomasz Podolecki; Zbigniew Kalarus; Radosław Lenarczyk
Journal:  Arch Med Sci       Date:  2018-08-07       Impact factor: 3.318

9.  The effect of preheated versus room-temperature skin disinfection on bacterial colonization during pacemaker device implantation: a randomized controlled non-inferiority trial.

Authors:  Camilla Wistrand; Bo Söderquist; Anders Magnusson; Ulrica Nilsson
Journal:  Antimicrob Resist Infect Control       Date:  2015-11-03       Impact factor: 4.887

10.  Atypical pathogens associated with cardiac implantable electronic device infections.

Authors:  Utkarsh Kohli; Aniruddha Hazra; Ahmed Shahab; Andrew D Beaser; Zaid A Aziz; Gaurav A Upadhyay; Cevher Ozcan; Roderick Tung; Hemal M Nayak
Journal:  Pacing Clin Electrophysiol       Date:  2021-07-26       Impact factor: 1.912

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.